In this expert-led video, Chris Mullin, Director of Global Strategy Services at NAMSA, shares practical guidance on how to build a strong Statistical Analysis Plan (SAP) tailored for FDA submissions. Whether you’re preparing for a pivotal trial or refining your regulatory strategy, this video offers essential insights to help you get it right.
What You’ll Learn:
- Core Components: Understand the key elements every SAP should include to meet FDA expectations
- Strategic Considerations: Learn how to align your statistical plan with your clinical objectives and regulatory pathway
- Expert Tips: Gain actionable advice from a seasoned regulatory strategist on avoiding common pitfalls and ensuring clarity in your submission
Ideal for clinical and regulatory professionals, this video will help you strengthen your FDA submission package and accelerate your path to market.